ClinicalTrials.Veeva

Menu

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

Hospitalized Patients

Treatments

Drug: Nirmatrelvir-Ritonavir

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The primary objective of the study was to assess the appropriateness of antiviral therapy with nirmatrelvir-ritonavir in hospitalized patients.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hospitalized patients receiving at least one dose nirmatrelvir-ritonavir

Exclusion criteria

  • None

Trial design

200 participants in 1 patient group

Nirmatrelvir-Ritonavir
Description:
Hospitalized patients receiving at least one dose Nirmatrelvir-Ritonavir
Treatment:
Drug: Nirmatrelvir-Ritonavir

Trial contacts and locations

1

Loading...

Central trial contact

Changcheng Shi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems